StonvexLoading…
StonvexStonvexStonvexCore line items from NNBR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $422.21M | $464.29M | $489.27M | $498.74M |
Operating Income | $-18.91M | $-27.55M | $-21.80M | $-21.09M |
Net Income | $-34.00M | $-38.27M | $-50.15M | $-26.10M |
EPS (Diluted) | $-1.07 | $-1.11 | $-1.35 | $-0.83 |
Total Assets | $440.78M | $456.89M | $510.88M | $546.13M |
Total Liabilities | $294.38M | $288.87M | $308.08M | $295.16M |
Cash & Equivalents | $11.38M | $18.13M | $21.90M | $12.81M |
Free Cash Flow OCF − CapEx | $-7.25M | $-7.24M | $8.85M | $-10.23M |
Shares Outstanding | 50.20M | 49.91M | 47.27M | 43.86M |